Incyte to Present at the 21st Annual BioCentury NewsMakers Conference

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26, 2014 at 2:00 p.m. (EDT) in New York.

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Contacts

Incyte Corporation
Pamela M. Murphy, 302-498-6944
Vice President, Investor Relations & Corporate Communications

Contacts

Incyte Corporation
Pamela M. Murphy, 302-498-6944
Vice President, Investor Relations & Corporate Communications